TrimRx's Blog

No. Semaglutide is contraindicated during pregnancy.

For three years semaglutide was the standard. Wegovy hit the market in 2021 with the STEP 1 trial showing 14.9% mean weight loss at 68 weeks.

Semaglutide is the most widely used GLP-1 medication on the market, with FDA approval for diabetes, obesity, and cardiovascular risk reduction.

Semaglutide is a weekly injectable GLP-1 agonist with established efficacy and FDA approval for diabetes, obesity, and cardiovascular risk reduction.

Liraglutide was the breakthrough GLP-1 of its decade.

Introduction Semaglutide isn’t FDA-approved for type 1 diabetes, but endocrinologists prescribe it off-label for select T1D patients with obesity or insulin resistance. The drug…

Introduction Patients switch between semaglutide formulations and other GLP-1 drugs for several reasons: insurance changes, cost, side effect tolerance, plateau on the current drug,…

Semaglutide is a peptide that degrades when exposed to heat, light, freezing, or repeated agitation.

Semaglutide’s side effect profile is dominated by gastrointestinal effects: nausea, vomiting, diarrhea, constipation, and reflux.